Evidence map›Paper›PMID 31692216›Full record

ArticleChembiochem : a European journal of chemical biology2020

Asymmetric Reduction of (R)-Carvone through a Thermostable and Organic-Solvent-Tolerant Ene-Reductase.

Dirk Tischler, Eric Gädke, Daniel Eggerichs, Alvaro Gomez Baraibar, Carolin Mügge, Anika Scholtissek, Caroline E Paul

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Toward Sustainability: Intensification of Light-Driven Whole Cell Biocatalysis.Chembiochem : a European journal of chemical biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Plant direct · 2023
    Article
  7. Article
  8. Tunable Production of (ACS catalysis · 2022
    Article
  9. Cell-Free Noncanonical Redox Cofactor Systems.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Screening a Strain ofMolecules (Basel, Switzerland) · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dirk TischlerFaculty of Biology and Biotechnology, Microbial Biotechnology, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.ORCID 0000-0002-6288-2403
Eric GädkeFaculty of Biology and Biotechnology, Microbial Biotechnology, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.
Daniel EggerichsFaculty of Biology and Biotechnology, Microbial Biotechnology, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.
Alvaro Gomez BaraibarFaculty of Biology and Biotechnology, Microbial Biotechnology, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.ORCID 0000-0001-7191-7316
Carolin MüggeFaculty of Biology and Biotechnology, Microbial Biotechnology, Ruhr-Universität Bochum, Universitätsstrasse 150, 44780, Bochum, Germany.ORCID 0000-0002-8065-173X
Anika ScholtissekEnvironmental Microbiology, TU Bergakademie Freiberg, Leipziger Strasse 29, 09599, Freiberg, Germany.ORCID 0000-0002-6506-1467
Caroline E PaulDepartment of Biotechnology, Delft University of Technology, Van der Maasweg 9, 2629, HZ, Delft, The Netherlands.ORCID 0000-0002-7889-9920

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ene-reductases allow regio- and stereoselective reduction of activated C=C double bonds at the expense of nicotinamide adenine dinucleotide cofactors [NAD(P)H]. Biological NAD(P)H can be replaced by synthetic mimics to facilitate enzyme screening and process optimization. The ene-reductase FOYE-1, originating from an acidophilic iron oxidizer, has been described as a promising candidate and is now being explored for applied biocatalysis. Biological and synthetic nicotinamide cofactors were evaluated to fuel FOYE-1 to produce valuable compounds. A maximum activity of (319.7±3.2) U mg

Indexed as

BiocatalysisCyclohexane MonoterpenesFlavoproteinsKineticsNADPOxidation-ReductionOxidoreductasesSolventsSubstrate SpecificitycarvoneCyclohexane MonoterpenesdihydrocarvoneFlavoproteinsNADPOxidoreductasesSolventsbiocatalysisbiotransformationscofactor mimicsOld Yellow Enzymesoxidoreductasessolvent stability

Identifiers

PMID31692216
PMCPMC7216909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.